| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
Low-toxicity Formulations of Polymyxins for Inhaled Treatment of Gram-negative Bacterial Lung Infections
2021-ZHOU-69256 |
Zhou, Qi | ||
|
Novel inhalation formulations of polymyxins
2020-ZHOU-68990 |
Zhou, Qi | ||
|
Composites with Ivacaftor and Colistin for Cystic Fibrosis and Bacterial Lung Infection Treatment
2020-ZHOU-68954 |
Zhou, Qi | ||
|
Combination Pharmaceutical Formulations
2018-ZHOU-68184 |
Zhou, Qi | ||
|
Novel Inhalation Formulation of Antimicrobials
2018-ZHOU-68233 |
Zhou, Qi | ||
|
Liposomal Formulation of Combinational Antibiotics
2018-ZHOU-68205 |
Zhou, Qi | ||
|
Dr. Qi (Tony) Zhou is an Associate Professor in the Department of Industrial and Physical Pharmacy of Purdue University. He has published over 100 journal articles and secured over $8M in research funding from government as well as industry. His research is focused on pharmaceutical formulation and manufacturing. Dr. Zhou's contributions to the field of pharmaceutical sciences have been recognized with many awards including 2016 IPEC Excipient Emerging Researcher Award, 2017 New Investigator Award in Aerosol Medicine, and 2021 AAPS Emerging Leader Award. Dr. Zhou is an Editor of AAPS PharmSciTech, Editorial Board Member of the International Journal of Pharmaceutics, Journal of Pharmaceuticals Sciences, and many other pharmaceutical journals. For more information on Qi Zhou, please visit his Purdue webpage: https://www.ipph.purdue.edu/faculty/zhou659 or his research page: https://www.researchgate.net/profile/Qi_Zhou13 |
|
|
